Guardant Health, Inc.

NasdaqGS:GH

Market Cap

USD 6.35 B

Share Price

USD 50.25

Avg Daily Volume

2,290,005

Change (1 day)

-2.03%

Change (1 year)

67.67%

Change (YTD)

64.48%

Guardant Health, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -53.52%

Guardant Health, Inc. EBIT Margin is -53.52% for the Trailing 12 Months (TTM) ending March 31, 2025, a -29.37% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Guardant Health, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -75.77%, a -44.72% change year over year.
  • Guardant Health, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -137.08%, a 34.73% change year over year.
  • Guardant Health, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -101.74%, a -3.03% change year over year.
  • Guardant Health, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -104.92%, a 224.42% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin